Predicting the Outcome of Patients with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia Treated with Alpha Blocker Monotherapy by Measurement of Bladder and Prostate Parameters Using Ultrasound

Single Versus Double Dose Tamsulosin for Patients with Moderate or Severe Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: Prospective Randomized Study

Evaluation of Silodosin in Comparison to Tamuslosin in Treatment of Benign Prostatic Hyperplasia with lower Urinary Tract Symptoms: A Prospective Study

Relationship between Benign Prostatic Hyperplasia Patients' Quality of Life and the Severity of Their Lower Urinary Tract Symptoms

Comparative study between monotherapy (tamsulosin 0.4mg versus tadalafil 5 mg) versus combined therapy in treatment of lower urinary tract symptoms of benign prostatic hyperplasia

Urodynamic Predictors for Voiding Recovery after Transurethral Resection of Prostate in Benign Prostatic Hyperplasia Patients with Significant Post-voiding Residual Urine

Safety and Efficacy of Silodosin versus Tadalafil in Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptoms; A prospective comparative study

Study of the Effect of Tamsulosin HCl (an Alpha-1 Receptor Antagonist) as a Medical Expelling Agent on Subsequent Ureteroscopic Procedure for Treatment of Lower Ureteric Stones

The Effect of Tamsulosin on Stone Free Rate after SWL: A Placebo Controlled Study

The efficacy of preoperative tamsulosin on ureteral dilatation during ureteroscopy